Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2014 1
2020 1
2021 4
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Emerging manufacturers engagements in the COVID -19 vaccine research, development and supply.
Pagliusi S, Jarrett S, Hayman B, Kreysa U, Prasad SD, Reers M, Hong Thai P, Wu K, Zhang YT, Baek YO, Kumar A, Evtushenko A, Jadhav S, Meng W, Dat DT, Huang W, Desai S. Pagliusi S, et al. Among authors: prasad sd. Vaccine. 2020 Jul 22;38(34):5418-5423. doi: 10.1016/j.vaccine.2020.06.022. Epub 2020 Jun 11. Vaccine. 2020. PMID: 32600908 Free PMC article.
Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infants.
P KK, Chiteti SR, Aileni VK, Babji S (late), Blackwelder WC, Kumar A, Vagha J, Nayak U, Mitra M, D N, Kar S, Yadav S, Naidu S, Mahantshetti N, Khalatkar V, Mohapatra S, Purthi PK, Sharma P, Kannan A, Dhongade RK, Prasad SD, Ella R, Vadrevu KM. P KK, et al. Among authors: prasad sd. Hum Vaccin Immunother. 2023 Dec 15;19(3):2278346. doi: 10.1080/21645515.2023.2278346. Epub 2023 Nov 15. Hum Vaccin Immunother. 2023. PMID: 37968237 Free PMC article. Clinical Trial.
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation.
Ganneru B, Jogdand H, Daram VK, Das D, Molugu NR, Prasad SD, Kannappa SV, Ella KM, Ravikrishnan R, Awasthi A, Jose J, Rao P, Kumar D, Ella R, Abraham P, Yadav PD, Sapkal GN, Shete-Aich A, Desphande G, Mohandas S, Basu A, Gupta N, Vadrevu KM. Ganneru B, et al. Among authors: prasad sd. iScience. 2021 Apr 23;24(4):102298. doi: 10.1016/j.isci.2021.102298. Epub 2021 Mar 10. iScience. 2021. PMID: 33723528 Free PMC article.
Clinical presentation of DFNB1.
McGuirt WT, Prasad SD, Cucci RA, Green GE, Smith RJ. McGuirt WT, et al. Among authors: prasad sd. Adv Otorhinolaryngol. 2002;61:113-9. doi: 10.1159/000066821. Adv Otorhinolaryngol. 2002. PMID: 12408072 No abstract available.
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model.
Mohandas S, Yadav PD, Shete-Aich A, Abraham P, Vadrevu KM, Sapkal G, Mote C, Nyayanit D, Gupta N, Srinivas VK, Kadam M, Kumar A, Majumdar T, Jain R, Deshpande G, Patil S, Sarkale P, Patil D, Ella R, Prasad SD, Sharma S, Ella KM, Panda S, Bhargava B. Mohandas S, et al. Among authors: prasad sd. iScience. 2021 Feb 19;24(2):102054. doi: 10.1016/j.isci.2021.102054. Epub 2021 Jan 9. iScience. 2021. PMID: 33521604 Free PMC article.
11 results